Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWIN
2126
Baldwin Insurance Group
BWIN
$3.05B
| $1.81M | ﹤0.01% |
46,600
+5,800
| +14% | +$271K |
|
2127
RF Industries
RFIL
$148M
| $1.81M | ﹤0.01% |
461,908
-14,400
| -3% | -$58.3K |
|
2128
Invesco S&P 500 Low Volatility ETF
SPLV
$7.23B
| $1.81M | ﹤0.01% |
+25,800
| New | +$1.86M |
|
|
SNT
2129
Senstar Technologies
SNT
$42.9M
| $1.81M | ﹤0.01% |
524,769
-10,100
| -2% | -$23.5K |
|
2130
Greif Class B
GEF.B
$4.2B
| $1.8M | ﹤0.01% |
26,500
-1,600
| -6% | -$113K |
|
2131
Equinox Gold
EQX
$13.5B
| $1.79M | ﹤0.01% |
+356,900
| New | +$1.99M |
|
2132
OP Bancorp
OPBK
$233M
| $1.78M | ﹤0.01% |
112,600
-5,800
| -5% | -$89K |
|
2133
Northrim BanCorp
NRIM
$606M
| $1.78M | ﹤0.01% |
91,200
-36,800
| -29% | -$704K |
|
2134
ICF International
ICFI
$1.59B
| $1.78M | ﹤0.01% |
+14,900
| New | +$2.23M |
|
2135
Mayville Engineering Co
MEC
$614M
| $1.77M | ﹤0.01% |
112,700
-14,191
| -11% | -$259K |
|
2136
Microvision
MVIS
$53M
| $1.77M | ﹤0.01% |
+90,048
| New | +$1.42M |
|
2137
Choiceone Financial
COFS
$514M
| $1.76M | ﹤0.01% |
49,500
+20,600
| +71% | +$706K |
|
2138
CVB Financial
CVBF
$4.09B
| $1.76M | ﹤0.01% |
82,188
-28,006
| -25% | -$592K |
|
2139
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $1.76M | ﹤0.01% |
40,100
+29,900
| +293% | +$1.4M |
|
2140
Amylyx Pharmaceuticals
AMLX
$2.41B
| $1.76M | ﹤0.01% |
464,400
+192,600
| +71% | +$906K |
|
2141
MacroGenics
MGNX
$268M
| $1.75M | ﹤0.01% |
538,523
+220,100
| +69% | +$793K |
|
|
AAMI
2142
Acadian Asset Management
AAMI
$3.28B
| $1.75M | ﹤0.01% |
66,328
+9,600
| +17% | +$269K |
|
2143
Insmed
INSM
$27B
| $1.75M | ﹤0.01% |
+25,287
| New | +$1.82M |
|
2144
Global X US Infrastructure Development ETF
PAVE
$14.4B
| $1.74M | ﹤0.01% |
+43,100
| New | +$1.85M |
|
2145
Blend Labs
BLND
$352M
| $1.74M | ﹤0.01% |
413,000
-636,360
| -61% | -$2.74M |
|
|
ENFN
2146
DELISTED
Enfusion, Inc.
ENFN
| $1.73M | ﹤0.01% |
168,397
+28,897
| +21% | +$279K |
|
2147
iShares Biotechnology ETF
IBB
$9.73B
| $1.73M | ﹤0.01% |
+13,100
| New | +$1.84M |
|
2148
Alector
ALEC
$219M
| $1.73M | ﹤0.01% |
915,738
+353,988
| +63% | +$1.33M |
|
|
SSBK
2149
DELISTED
Southern States Bancshares
SSBK
| $1.73M | ﹤0.01% |
51,900
-7,201
| -12% | -$243K |
|
2150
China Automotive Systems
CAAS
$142M
| $1.73M | ﹤0.01% |
420,994
+19,100
| +5% | +$83.5K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.